Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Granite Announces Voting Results From Its 2021 Joint Annual General Meetings of Stapled Unitholders: https://mms.businesswire.com/media/20191217005844/en/763597/5/Granite_REIT_rgb.png.jpg
Granite Announces Voting Results From Its 2021 Joint Annual General Meetings of Stapled Unitholders


Granite Real Estate Investment Trust (“Granite REIT”) (TSX: GRT.UN / NYSE: GRP.U) and Granite REIT Inc. (“Granite GP”) announced today the results of the matters voted on at their joint annual

GenSight Biologics Appoints Marion Ghibaudo as Chief Technical Officer to Lead GS030 Device Engineering: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Appoints Marion Ghibaudo as Chief Technical Officer to Lead GS030 Device Engineering


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Lysogene Announces First Patient Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis
Lysogene Announces First Patient Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis


Regulatory News:



Lysogene (Paris:LYS) (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today announced dosing of the first patient

Granite REIT Announces Closing of C$316 Million Bought Deal Equity Offering: https://mms.businesswire.com/media/20191217005844/en/763597/5/Granite_REIT_rgb.png.jpg
Granite REIT Announces Closing of C$316 Million Bought Deal Equity Offering


Granite Real Estate Investment Trust (“Granite” or the “REIT”) (TSX: GRT.UN / NYSE: GRP.U) announced today that it has closed its previously announced public offering (the “Offering”) of 3,979,000

CI Global Asset Management Announces Appointment of Marc-André Lewis as Executive Vice-President and Head of Investment Management: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Global Asset Management Announces Appointment of Marc-André Lewis as Executive Vice-President and Head of Investment Management


CI Global Asset Management (“CI GAM”) today announced the appointment of Marc-André Lewis, an accomplished investment professional with extensive global experience, as its Executive Vice-President

CI Financial Announces Pricing of US$900 Million Notes Offering: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial Announces Pricing of US$900 Million Notes Offering


CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX), a diversified global asset and wealth management company, announced today that it has priced an underwritten public offering of US$900 million

Qumu Enlists Channel Sales Veteran Susan Young to Grow Strategic Partner Ecosystem: https://mms.businesswire.com/media/20210421005269/en/872964/5/qumu-logo-padded.jpg
Qumu Enlists Channel Sales Veteran Susan Young to Grow Strategic Partner Ecosystem


Qumu Corporation (Nasdaq: QUMU), a leading provider of cloud-based enterprise video technology, today announced that Susan Young has joined the Qumu team as vice president of strategic alliances

CORRECTING and REPLACING CI Global Asset Management Continues Integration of its Global Investment Platform with Team-Based Approach to Dividend and Canadian Equity Strategies
CORRECTING and REPLACING CI Global Asset Management Continues Integration of its Global Investment Platform with Team-Based Approach to Dividend and Canadian Equity Strategies


Please replace the release with the following corrected version due to revisions to the table of portfolio management appointments.



The updated release reads:



CI GLOBAL ASSET MANAGEMENT

GenSight Biologics Announces Publication of Indirect Comparison Showing Treatment Effect of LUMEVOQ® versus Natural History in Frontiers in Neurology: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Announces Publication of Indirect Comparison Showing Treatment Effect of LUMEVOQ® versus Natural History in Frontiers in Neurology


Regulatory News:



GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies

GenSight Biologics to Host a Key Opinion Leader Webinar on the Nature Medicine Case Report: Visual Recovery after GS030 Optogenetic Treatment: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics to Host a Key Opinion Leader Webinar on the Nature Medicine Case Report: Visual Recovery after GS030 Optogenetic Treatment


Regulatory News:



GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies

Mannatech Commences Cash Tender Offer to Purchase up 211,538 Shares of Its Common Stock at a Cash Purchase Price of $26.00 per Share: https://mms.businesswire.com/media/20210511005229/en/877334/5/logo-mannatech-schema.jpg
Mannatech Commences Cash Tender Offer to Purchase up 211,538 Shares of Its Common Stock at a Cash Purchase Price of $26.00 per Share


Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announces today it has commenced

Mannatech Announces Intent to Commence a Cash Tender Offer to Purchase up to 211,538 Shares of Its Common Stock at a Purchase Price of $26.00 per Share: https://mms.businesswire.com/media/20210511005229/en/877334/5/logo-mannatech-schema.jpg
Mannatech Announces Intent to Commence a Cash Tender Offer to Purchase up to 211,538 Shares of Its Common Stock at a Purchase Price of $26.00 per Share


Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, intends to conduct a cash tender

Assante Wealth Management Achieves Top Ranking in J.D. Power 2021 Canada Full-Service Investor Satisfaction Study: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
Assante Wealth Management Achieves Top Ranking in J.D. Power 2021 Canada Full-Service Investor Satisfaction Study


Assante Wealth Management (“Assante”) announces that it has been ranked highest in overall investor satisfaction with full-service investment firms in the J.D. Power 2021 Canada Full-Service

 
MND : New major snowmaking project in Russia
MND : New major snowmaking project in Russia

MND, the French industrial group specializing in ropeway mobility, snowmaking systems, mountain safety and sensational leisure infrastructures, has been selected in an international tender to supply

CI Financial Reports Record Total Assets of $287.5 Billion for April 2021: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial Reports Record Total Assets of $287.5 Billion for April 2021


CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary assets under management as at April 30, 2021 of $141.0 billion and wealth management assets of $146.5 billion, for total

 
METABOLIC EXPLORER : METEX provides an update on the situation at its Amiens plant.
METABOLIC EXPLORER : METEX provides an update on the situation at its Amiens plant.

METEX provides an update on the situation at its Amiens plant

Clermont-Ferrand, May 26, 2021 – (FR0004177046 METEX), METabolic EXplorer (METEX), specialized in the design, development and

Mannatech Declares First Quarter 2021 Dividend: https://mms.businesswire.com/media/20210511005229/en/877334/5/logo-mannatech-schema.jpg
Mannatech Declares First Quarter 2021 Dividend


Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend

 
MND : 2020/2021 half-year results - Outlook for second-half 2020/2021
MND : 2020/2021 half-year results - Outlook for second-half 2020/2021

2020/2021 half-year results

Solid resilience in activity, decline limited to -5%

Operational break-even target (adjusted EBITDA) achieved in H1

 

Outlook for second-half 2020/2021

Sustained business

Granite Announces Renewal of Normal Course Issuer Bid: https://mms.businesswire.com/media/20191217005844/en/763597/5/Granite_REIT_rgb.png.jpg
Granite Announces Renewal of Normal Course Issuer Bid


Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN / NYSE: GRP.U) (“Granite REIT” and “Granite GP”, and, collectively “Granite”) today announced the acceptance by the Toronto

GenSight Biologics Appoints Country Leads for France, Germany and the UK in Preparations for LUMEVOQ® Commercial Launch: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Appoints Country Leads for France, Germany and the UK in Preparations for LUMEVOQ® Commercial Launch


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Granite REIT Declares Distribution for May 2021: https://mms.businesswire.com/media/20191217005844/en/763597/5/Granite_REIT_rgb.png.jpg
Granite REIT Declares Distribution for May 2021


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CAD $0.250 per stapled unit for the month of

 
GECI INTERNATIONAL : 2020-21 FULL-YEAR REVENUES
GECI INTERNATIONAL : 2020-21 FULL-YEAR REVENUES

GECI International, the Digital Transformation and Technology Consulting specialist, is reporting pro forma1 full-year revenues of €16.5m, down 26% from the previous year on a comparable basis.

 

GenSight Biologics Appoints Françoise de Craecker to its Board of Directors: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Appoints Françoise de Craecker to its Board of Directors


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

FG Financial Group, Inc. Reports First Quarter 2021 Financial Results
FG Financial Group, Inc. Reports First Quarter 2021 Financial Results


FG Financial Group, Inc. (Nasdaq:FGF) (the “Company”), a reinsurance and investment management holding company focused on opportunistic collateralized and loss capped reinsurance, while allocating

FG Financial Group, Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A
FG Financial Group, Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A


FG Financial Group, Inc. (Nasdaq:FGF) (the “Company”), a reinsurance and investment management holding company focused on opportunistic collateralized and loss capped reinsurance, while allocating